The Sickle Cell Disease Treatment Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Sickle Cell Disease Treatment Market?
The market size for sickle cell disease treatment has experienced significant expansion lately. The size of the market is projected to increase from $2.95 billion in 2024 to $3.54 billion in 2025, with a compound annual growth rate (CAGR) of 19.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Sickle Cell Disease Treatment Industry?
The market size of the global sickle cell disease treatment is predicated to reach $6.8 billion in 2029, growing at a compound annual growth rate (CAGR) of 17.7%.
Download Your Free Sample of the 2025 Sickle Cell Disease Treatment Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Sickle Cell Disease Treatment Market?
The key drivers in the sickle cell disease treatment market are:
• Advancements in gene editing and gene therapy techniques
• Development of new drugs for sickle cell disease treatment
• Increasing use of telemedicine and remote monitoring in healthcare
• The execution of various global health initiatives for sickle cell disease treatment
Global Market Segmentation: Identifying Major Sickle Cell Disease Treatment Industry Segments
The sickle cell disease treatment market covered in this report is segmented –
1) By Treatment Modality: Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant
2) By Disease Type: Sickle Cell Anemia, Hemoglobin Sickle C Disease (HbSC), Other Disease Types
3) By Route Of Administration: Oral, Parenteral
4) By End-User: Hospitals, Specialty Clinics, Other End-Users
Pre-order the 2025 Sickle Cell Disease Treatment Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Sickle Cell Disease Treatment Market?
The key trends in the sickle cell disease treatment market are:
• The future market is expected to be influenced by gene editing and gene therapy developments.
• The advent of new drug developments is shaping the future of the market.
• The market trend is leaning towards telemedicine and remote monitoring practices.
• The influence of global health initiatives, patient advocacy and engagement is an emerging trend.
Who Are the Top Competitors & Leading Players in the Sickle Cell Disease Treatment Market?
Major companies in the sickle cell disease treatment market are:
• Sun Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Johnson & Johnson Private Limited
• Merck & Co Inc.
• Novartis AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Vertex Pharmaceuticals Incorporated
• Alnylam Pharmaceuticals Inc.
• Ionis Pharmaceuticals Inc.
• Silver Lake Research Corporation
• Global Blood Therapeutics Inc.
• Acceleron Pharma Inc.
• Sangamo Therapeutics Inc.
• Medunik USA Inc.
• Zydus Cadila Healthcare Ltd.
• Graphite Bio Inc.
• Addmedica
• Emmaus Medical Inc.
• Bluebird bio Inc.
• CRISPR Therapeutics AG
• GlycoMimetics Inc.
• Arena Pharmaceuticals Inc.
• Mast Therapeutics Inc.
Regional Dominance: Which Area Leads the Global Sickle Cell Disease Treatment Market?
North America was the largest region in the sickle cell disease treatment market in 2024
